Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

80.35 USD +0.86 (+1.08%)
Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Arena Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9 Next >
Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Expectations
Following the market opening Thursday, the Dow traded down 0.57 percent to 24,938.48 while the NASDAQ declined 0.22 percent to 7,120.69. ... 
Tags SWCH PXS ARNA
From Benzinga
34 Stocks Moving In Thursday's Pre-Market Session
Gainers XpresSpa Group Inc (NASDAQ: XSPA) rose 23.4 percent to $0.22 in pre-market trading after the company reported Q3 EPS up ... 
Tags Movers & Shakers Benzinga Pre/Market Outlook
From Benzinga
United Therapeutics to develop, sell Arena Pharma's hypertension treatment
United Therapeutics Corp on Thursday signed a deal potentially worth up to $1.2 billion for the rights to develop and sell Arena Pharmaceuticals Inc's pulmonary arterial hypertension treatment,... 
Tags companyNews
From Reuters: Company News
34 Stocks Moving In Friday's Pre-Market Session
Gainers Finisar Corporation (NASDAQ: FNSR) shares rose 28 percent to $24.17 in pre-market trading after II-VI announced plans to ... 
Tags ACRX News Pre/Market Outlook
From Benzinga
Arena Pharmaceuticals Shows Market Leadership With Jump To 83 RS Rating
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags KOD ALLK KIN
From Benzinga
Cramer's lightning round: This stock could recover if the Democrats win the House
Jim Cramer says a biotechnology stock could launch a recovery if the midterm elections bring a blue wave to Congress. 
Tags Celgene Corp Mad Money Canada Goose Holdings Inc
From CNBC.com News
Arena Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 81. 
From Investor's Business Daily
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy ... 
Tags PTCT VNDA MLNT
From Benzinga
Interesting ARNA Put And Call Options For December 14th
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading today, for the December 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Analysts Anticipate FYC To Hit $55
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Arena Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark
Arena Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Stock Upgrades: Arena Pharmaceuticals Shows Rising Relative Strength
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 87. 
From Investor's Business Daily
The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags GRTS VCYT IBB
From Benzinga
Notable Friday Option Activity: WGO, ARNA, RMBS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Winnebago Industries, Inc. (WGO), where a total volume of 3,081 contracts has been... 
Tags Stocks
From Market News Video
Analysts Predict 10% Upside For The Holdings of FYX
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biotech Rises On Crohn's Disease Study For Cannabinoid Drug
Arena Pharmaceuticals jumped early Tuesday on promising data for its non-opioid treatment for Crohn's disease pain. 
From Investor's Business Daily
Morning Call For Tuesday, Sept. 25
Dec E-mini S&Ps (ESZ18 +0.18%) this morning are up +0.26% and European stocks are up +0.33% as strength in energy stocks leads the overall market higher. 
Tags Stocks / Equities Futures Commodities
From Blogs - TalkMarkets
The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags Trading Ideas IBB EW
From Benzinga
After-hours buzz: CTL, ARNA & more
See which stocks are posting big moves after the bell on Monday. 
Tags CenturyLink Inc PetIQ Inc Market Insider
From CNBC.com News
The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ ... 
Tags ATRS RDUS LOXO
From Benzinga
Arena Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81. 
From Investor's Business Daily
Arena Pharmaceuticals Earns Relative Strength Rating Upgrade
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Arena Pharmaceuticals (ARNA) Shares Cross Above 200 DMA
In trading on Friday, shares of Arena Pharmaceuticals Inc (ARNA) crossed above their 200 day moving average of $39.03, changing hands as high as $39.20 per share. Arena Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
Implied PTH Analyst Target Price: $110
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
It’s the last week before the Benzinga Cannabis Capital Conference, the premier gathering of cannabis entrepreneurs and investors ... 
Tags APHQF invest in marijuana Cannabis
From Benzinga
Stocks Showing Improving Market Leadership: Arena Pharmaceuticals Earns 85 RS Rating
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
7 Stocks Moving In Monday's After-Hours Session
Gainers Twilio Inc (NYSE: TWLO) shares are up 15 percent after reporting second-quarter earnings beat. Earnings came in at 3 cents ... 
Tags ZG Market News Z
From Benzinga
Arena Pharmaceuticals Q2 Earnings Outlook
Arena Pharmaceuticals (NASDAQ: ARNA) announces its next round of earnings Monday. Here is Benzinga's everything-that-matters guide ... 
Tags Market News ARNA Earnings
From Benzinga
How The Pieces Add Up: JKK Headed For $224
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback